Literature DB >> 11156630

Hepatocellular carcinoma: is surveillance cost effective?

J Bruix1, J M Llovet.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11156630      PMCID: PMC1728216          DOI: 10.1136/gut.48.2.149

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.

Authors:  Eiman Aleem; Ayman Elshayeb; Nihal Elhabachi; Amal Refaat Mansour; Ahmed Gowily; Asmaa Hela
Journal:  Oncol Lett       Date:  2011-12-30       Impact factor: 2.967

2.  Identifying genes for establishing a multigenic test for hepatocellular carcinoma surveillance in hepatitis C virus-positive cirrhotic patients.

Authors:  Kellie J Archer; Valeria R Mas; Krystle David; Daniel G Maluf; Karen Bornstein; Robert A Fisher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

3.  Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs.

Authors:  John Fp Bridges; Gisselle Gallego; Barri M Blauvelt
Journal:  Health Res Policy Syst       Date:  2011-07-28

4.  An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.

Authors:  Sabrina Bimonte; Antonio Barbieri; Raffaele Palaia; Maddalena Leongito; Vittorio Albino; Mauro Piccirillo; Claudio Arra; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2015-03-09       Impact factor: 2.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.